LGVN (longeveron.com) יחס שווי פעילות להכנסות

Longeveron (LGVN) - לוגו תאגידי

The enterprise value-to-revenue multiple confirms the high reputation of Longeveron Inc. (LGVN) in regenerative medicine due to the development of safe Alzheimer's treatments, where -598.29 represents the current metric level. Innovations in cellular tissue restoration for longevity combine with investor confidence in the updated management following the publication of successful clinical results.

Longeveron Corporation (LGVN): יחס שווי פעילות להכנסות מ-23.11.2025 עד 20.11.2026

LGVN (Longeveron Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

- מחיר ותחזית קונצנזוס למחירים:
- מדדי הערכת שווי שוק של העסק:
הערכת שווי פונדמנטלית:Longeveron Inc. LGVN
מוצר עיקרי של Longeveron Corporation

Longeveron Inc. utilizes its own drug production laboratories to minimize external costs, which directly impacts the dynamics of the enterprise value-to-annual revenue multiple. This indicator compares market capitalization, adjusted for net debt, against sales volume, allowing investors to assess the fairness of the current business valuation; however, abnormally low values may signal fundamental risks or a "value trap."